Response

Chest. 2018 Jun;153(6):1509-1510. doi: 10.1016/j.chest.2018.03.010.

Authors

Vincent Yi-Fong Su¹, Wei-Juin Su²

Affiliations

¹ Department of Internal Medicine, Taipei City Hospital Yangming Branch, Taipei, Taiwan; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
² Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan. Electronic address: wjsu.mail@gmail.com.

PMID: 29884264
DOI: 10.1016/j.chest.2018.03.010

No abstract available

Publication types

Letter
Comment

MeSH terms

Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Risk

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors